SCHEMBL8089215

SCHEMBL8089215

O=C(NO)c1ccccc1-c1ccc(-c2ccccc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 4/20 0.62
CHRNB4 P30926 4/20 0.62
CHRNA3 P32297 4/20 0.62
CHRNA4 P43681 4/20 0.62
HDAC7 Q8WUI4 3/20 0.60
MMP1 P03956 1/20 0.57
MMP2 P08253 1/20 0.57
MMP3 P08254 1/20 0.57
MMP9 P14780 1/20 0.57
MMP8 P22894 1/20 0.57
MMP12 P39900 1/20 0.57
MMP13 P45452 1/20 0.57
MMP14 P50281 1/20 0.57
MMP16 P51512 1/20 0.57
BCAT2 O15382 1/20 0.55
ALDH1A1 P00352 3/20 0.54
HTT P42858 2/20 0.54
GAA P10253 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.53
MEN1 O00255 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL975666 0.96 CHRNB2 (0.67) CHRNB2CHRNB4CHRNA3CHRNA4HDAC7
SCHEMBL27460658 0.94 HDAC7 (0.67) CHRNB2CHRNB4CHRNA3CHRNA4HDAC7
SCHEMBL12922045 0.89 HDAC7 (0.60) CHRNB2CHRNB4CHRNA3CHRNA4HDAC7
SCHEMBL12922053 0.87 HDAC8 (0.59) CHRNB2CHRNB4CHRNA3CHRNA4HDAC7
SCHEMBL974404 0.85 SLC6A3 (0.63) CHRNB2CHRNB4CHRNA3CHRNA4HDAC7
SCHEMBL12922063 0.85 HDAC7 (0.71) CHRNB2CHRNB4CHRNA3CHRNA4HDAC7
SCHEMBL13845096 0.85 HDAC7 (0.66) CHRNB2CHRNB4CHRNA3CHRNA4HDAC7
SCHEMBL12922050 0.85 HDAC7 (0.57) CHRNB2CHRNB4CHRNA3CHRNA4HDAC7
SCHEMBL3026631 0.83 GAA (0.64) CHRNB2CHRNB4CHRNA3CHRNA4HDAC7
SCHEMBL25060939 0.83 HDAC7 (0.73) CHRNB2CHRNB4CHRNA3CHRNA4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8673911-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2014-03-18 US disclosed
US-8673911-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2014-03-18 US disclosed
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2014-02-13 US disclosed
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2014-02-13 US disclosed
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2011-01-27 US disclosed
WO-2009055917-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2009-05-07 WO disclosed
EP-0379057-B1 Mesogenic epoxy compounds DOW CHEMICAL CO (US) 2000-12-06 EP disclosed
US-5736620-A ENHANCED UNIDIRECTIONAL, MECHANICAL PROPERTIES AT LOWER TEMPERATURE THE DOW CHEMICAL COMPANY (US) 1998-04-07 US disclosed
US-5463091-A Liquid crystals, polyepoxides THE DOW CHEMICAL COMPANY (US) 1995-10-31 US disclosed
US-5391651-A Curable mixtures of mesogenic epoxy resins and mesogenic polyamines and cured compositions THE DOW CHEMICAL COMPANY (US) 1995-02-21 US disclosed
US-5296570-A Curable mixtures of mesogenic epoxy resins and mesogenic polyamines and cured compositions THE DOW CHEMICAL COMPANY (US) 1994-03-22 US disclosed
US-5292831-A Enhanced unidirectional, mechanical properties THE DOW CHEMICAL COMPANY (US) 1994-03-08 US disclosed
US-5270405-A Mesogenic epoxy compounds THE DOW CHEMICAL COMPANY (US) 1993-12-14 US disclosed
US-5270404-A Curable compositions of mesogen-containing advanced epoxy resins and curing agents therefor THE DOW CHEMICAL COMPANY (US) 1993-12-14 US disclosed
US-5266660-A Curable compositions containing mesogenic epoxy compounds and cured products thereof THE DOW CHEMICAL CO. (US) 1993-11-30 US disclosed
US-5227452-A Curable mixtures of mesogenic epoxy resins and mesogenic polyamines and cured compositions THE DOW CHEMICAL COMPANY (US) 1993-07-13 US disclosed
US-5218062-A Curable mixtures of mesogenic epoxy resins and mesogenic polyamines and cured compositions THE DOW CHEMICAL COMPANY (US) 1993-06-08 US disclosed
EP-0473935-A2 Curable mixture of mesogenic epoxy resins and mesogenic polyamines and cured compositions THE DOW CHEMICAL COMPANY (US) 1992-03-11 EP disclosed
EP-0379057-A2 Mesogenic epoxy compounds THE DOW CHEMICAL COMPANY (US) 1990-07-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC11, HDAC3 CHRNB2 2327/4885CHRNB4 2355/4885CHRNA3 1459/4885
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC11, HDAC3 CHRNB2 2327/4885CHRNB4 2355/4885CHRNA3 1459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.